Penicillamine Tablet
Product Images NDC 70748-153
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Penicillamine (NDC 70748-153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 02 (Cd2c8cf5 209b 4473 Bf16 Cd231f024009 02)
Image 03 (Cd2c8cf5 209b 4473 Bf16 Cd231f024009 03)
Image 04 (Cd2c8cf5 209b 4473 Bf16 Cd231f024009 04)
This is a description of a medication called Penicillamine which comes in a film-coated tablet form containing 250mg of penicillamine USP. The usual dosage information is contained in the accompanying information. Storage directions indicate that it should be kept at a controlled room temperature and protected from moisture. The medication is manufactured for Lupin Pharmaceuticals, Inc. based in Maryland, USA, and Lupin Limited in Nagpur, India. The text also includes information on excursions outside of the recommended temperature range and dispensing information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.